New Delhi: The company had posted a consolidated net profit of Rs 403.64 crore in the same quarter last financial year, Dabur India said in a regulatory filing.
Dabur India said the company “reported a strong growth in its performance for the second quarter of 2020-21, backed by sustained efforts in driving demand for its ayurvedic healthcare, hygiene and nutrition products, coupled with strong innovation to meet the emerging consumer needs in the wake of the COVID pandemic”. Revenue from operations stood at Rs 2,516.04 crore in the second quarter of the current fiscal as against Rs 2,211.97 crore in the year-ago period, a growth of 13.74 per cent, it added.
Commenting on the financial performance, Dabur India Chief Executive Officer Mohit Malhotra said: “While COVID-19 continues to impact people around the world, Dabur India Ltd’s strategic business transformation exercise to develop and implement aggressive growth strategies in the core business areas and successfully address the emerging challenges helped us deliver a healthy topline growth accompanied by an expansion in margin”. Malhotra said Dabur continued to focus on strengthening its core healthcare portfolio with the introduction of new innovations, coupled with heavy investments behind its power brands and expanding its distribution might.
